14 results on '"Moriyama, Yoshinori"'
Search Results
2. Antenatal prediction models for outcomes of extremely and very preterm infants based on machine learning.
- Author
-
Ushida, Takafumi, Kotani, Tomomi, Baba, Joji, Imai, Kenji, Moriyama, Yoshinori, Nakano-Kobayashi, Tomoko, Iitani, Yukako, Nakamura, Noriyuki, Hayakawa, Masahiro, and Kajiyama, Hiroaki
- Subjects
- *
PREMATURE infants , *MACHINE learning , *PREDICTION models , *RECEIVER operating characteristic curves , *BIRTH weight - Abstract
Purpose: Predicting individual risks for adverse outcomes in preterm infants is necessary for perinatal management and antenatal counseling for their parents. To evaluate whether a machine learning approach can improve the prediction of severe infant outcomes beyond the performance of conventional logistic models, and to identify maternal and fetal factors that largely contribute to these outcomes. Methods: A population-based retrospective study was performed using clinical data of 31,157 infants born at < 32 weeks of gestation and weighing ≤ 1500 g, registered in the Neonatal Research Network of Japan between 2006 and 2015. We developed a conventional logistic model and 6 types of machine learning models based on 12 maternal and fetal factors. Discriminative ability was evaluated using the area under the receiver operating characteristic curves (AUROCs), and the importance of each factor in terms of its contribution to outcomes was evaluated using the SHAP (SHapley Additive exPlanations) value. Results: The AUROCs of the most discriminative machine learning models were better than those of the conventional models for all outcomes. The AUROCs for in-hospital death and short-term adverse outcomes in the gradient boosting decision tree were significantly higher than those in the conventional model (p = 0.015 and p = 0.002, respectively). The SHAP value analyses showed that gestational age, birth weight, and antenatal corticosteroid treatment were the three most important factors associated with severe infant outcomes. Conclusion: Machine learning models improve the prediction of severe infant outcomes. Moreover, the machine learning approach provides insight into the potential risk factors for severe infant outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Optimal annual body mass index change for preventing spontaneous preterm birth in a subsequent pregnancy.
- Author
-
Tano, Sho, Kotani, Tomomi, Ushida, Takafumi, Yoshihara, Masato, Imai, Kenji, Nakano-Kobayashi, Tomoko, Moriyama, Yoshinori, Iitani, Yukako, Kinoshita, Fumie, Yoshida, Shigeru, Yamashita, Mamoru, Kishigami, Yasuyuki, Oguchi, Hidenori, and Kajiyama, Hiroaki
- Subjects
- *
BODY mass index , *PREMATURE labor , *WEIGHT gain , *NEONATAL mortality , *PREGNANCY - Abstract
Preterm birth (PTB) is a leading cause of neonatal morbidity and mortality. Although PTB is known to recur, interpregnancy preventive strategies for PTB have not been established to date. Annual BMI change can serve as a specific target value for preventing obstetric complications during interpregnancy care/counseling. This value can also account for age-related weight gain (0.2 kg/m2/year). In a multicenter retrospective study, we investigated the optimal annual BMI change for preventing PTB recurrence using the data of individuals who had two singleton births from 2009 to 2019. The association between annual BMI change and spontaneous PTB (sPTB) was analyzed by separating cases of medically indicated PTB (mPTB) from those of sPTB. Previous history of sPTB was strongly associated with sPTB in the subsequent pregnancy (adjusted odds ratio [aOR], 12.7; 95% confidence interval [CI], 6.5–24.8). Increase in annual BMI was negatively associated with sPTB (aOR, 0.6; 95% CI 0.5–0.9). The sPTB recurrence rate was significantly lower in patients with an annual BMI change of ≥ 0.25 kg/m2/year than in those with an annual BMI change of < 0.25 kg/m2/year (7.7% vs. 35.0%, p = 0.011). Our findings suggest that age-related annual BMI gain between pregnancies may help prevent sPTB recurrence. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Pre-pregnancy sleep duration and postpartum depression: a multicenter study in Japan.
- Author
-
Matsuo, Seiko, Ushida, Takafumi, Iitani, Yukako, Imai, Kenji, Nakano-Kobayashi, Tomoko, Moriyama, Yoshinori, Yoshida, Shigeru, Yamashita, Mamoru, Kajiyama, Hiroaki, and Kotani, Tomomi
- Subjects
- *
RESEARCH , *STATISTICS , *POSTPARTUM depression , *ACQUISITION of data methodology , *CONFIDENCE intervals , *MULTIVARIATE analysis , *PUBLIC health , *MEDICAL cooperation , *RETROSPECTIVE studies , *REGRESSION analysis , *SLEEP , *PREGNANCY complications , *MEDICAL records , *DESCRIPTIVE statistics , *ODDS ratio , *PRECONCEPTION care , *EDINBURGH Postnatal Depression Scale - Abstract
Postpartum depression (PPD) is as a major public health issue and clinical priority worldwide. This study aimed to investigate the association between pre-pregnancy sleep duration and PPD. A multicenter retrospective study was conducted using clinical data of women who delivered at term between 2014 and 2018 at 12 maternity care hospitals in Japan. A total of 15,314 women were stratified into five groups according to their pre-pregnancy sleep duration: < 6, 6–7, 7–8, 8–9, and ≥ 9 h. Univariate and multivariate regression analyses were conducted to determine whether pre-pregnancy sleep duration affects the Edinburgh Postnatal Depression Scale (EPDS) scores at 1 month postpartum. We also evaluated whether the risk for PPD differs between primipara and multipara women classified according to pre-pregnancy sleep duration. The adjusted odds ratio for high EPDS scores (≥ 9) among women who slept for < 6 h and 6–7 h was 2.08 (95% confidence interval [CI]: 1.60–2.70) and 1.41 (95% CI: 1.18–1.68), respectively, relative to that in women with 7–8 h of sleep as the reference group. A 1-h increase in sleep duration was associated with an approximately 14% reduction in the risk for high EPDS scores. The association between short sleep duration and high EPDS scores was more remarkable in multipara women than in primipara women. Short pre-pregnancy sleep duration is associated with high EPDS scores, and this association is more significant in multipara women than in primipara women. Our findings emphasize the importance of collecting information on pre-pregnancy sleep duration to identify women at a high risk for PPD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Annual body mass index gain and risk of hypertensive disorders of pregnancy in a subsequent pregnancy.
- Author
-
Tano, Sho, Kotani, Tomomi, Ushida, Takafumi, Yoshihara, Masato, Imai, Kenji, Nakano-Kobayashi, Tomoko, Moriyama, Yoshinori, Iitani, Yukako, Kinoshita, Fumie, Yoshida, Shigeru, Yamashita, Mamoru, Kishigami, Yasuyuki, Oguchi, Hidenori, and Kajiyama, Hiroaki
- Subjects
- *
BODY mass index , *WEIGHT gain , *PREGNANCY , *PREGNANT women , *HYPERTENSION - Abstract
Weight gain during interpregnancy period is related to hypertensive disorders of pregnancy (HDP). However, in interpregnancy care/counseling, the unpredictability of the timing of the next conception and the difficulties in preventing age-related body weight gain must be considered while setting weight management goals. Therefore, we suggest considering the annual change in the body mass index (BMI). This study aimed to clarify the association between annual BMI changes during the interpregnancy period and HDP risk in subsequent pregnancies. A multicenter retrospective study of data from 2009 to 2019 examined the adjusted odds ratio (aOR) of HDP in subsequent pregnancies. The aORs in several annual BMI change categories were also calculated in the subgroups classified by HDP occurrence in the index pregnancy. This study included 1,746 pregnant women. A history of HDP (aOR, 16.76; 95% confidence interval [CI], 9.62 − 29.22), and annual BMI gain (aOR, 2.30; 95% CI, 1.76 − 3.01) were independent risk factors for HDP in subsequent pregnancies. An annual BMI increase of ≥ 1.0 kg/m2/year was related to HDP development in subsequent pregnancies for women without a history of HDP. This study provides data as a basis for interpregnancy care/counseling, but further research is necessary to validate our findings and confirm this relationship. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Dynamin-related protein 1 deficiency accelerates lipopolysaccharide-induced acute liver injury and inflammation in mice.
- Author
-
Wang, Lixiang, Li, Xin, Hanada, Yuki, Hasuzawa, Nao, Moriyama, Yoshinori, Nomura, Masatoshi, and Yamamoto, Ken
- Subjects
- *
LIPOPOLYSACCHARIDES , *LIVER injuries , *DYNAMIN (Genetics) , *PROTEIN deficiency , *DISEASE progression , *MITOCHONDRIAL pathology - Abstract
Mitochondrial fusion and fission, which are strongly related to normal mitochondrial function, are referred to as mitochondrial dynamics. Mitochondrial fusion defects in the liver cause a non-alcoholic steatohepatitis-like phenotype and liver cancer. However, whether mitochondrial fission defect directly impair liver function and stimulate liver disease progression, too, is unclear. Dynamin-related protein 1 (DRP1) is a key factor controlling mitochondrial fission. We hypothesized that DRP1 defects are a causal factor directly involved in liver disease development and stimulate liver disease progression. Drp1 defects directly promoted endoplasmic reticulum (ER) stress, hepatocyte death, and subsequently induced infiltration of inflammatory macrophages. Drp1 deletion increased the expression of numerous genes involved in the immune response and DNA damage in Drp1LiKO mouse primary hepatocytes. We administered lipopolysaccharide (LPS) to liver-specific Drp1-knockout (Drp1LiKO) mice and observed an increased inflammatory cytokine expression in the liver and serum caused by exaggerated ER stress and enhanced inflammasome activation. This study indicates that Drp1 defect-induced mitochondrial dynamics dysfunction directly regulates the fate and function of hepatocytes and enhances LPS-induced acute liver injury in vivo. Wang et al. report that deficiency of dynamin-related protein 1, which controls mitochondrial fission, accelerates lipopolysaccharide-induced acute liver injury and inflammation in mice. Thus, they highlight mitochondria dynamics dysfunction as a new mechanism of liver disease development. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. Drug-induced pneumonitis caused by sulfamethoxazole, trimethoprim during treatment of Pneumocystis carinii pneumonia in a patient with refractory ulcerative colitis.
- Author
-
Oshitani, Nobuhide, Matsumoto, Takayuki, Moriyama, Yoshinori, Kudoh, Shinzo, Hirata, Kazuto, Kuroki, Tetsuo, Oshitani, N, Matsumoto, T, Moriyama, Y, Kudoh, S, Hirata, K, and Kuroki, T
- Subjects
- *
ULCERATIVE colitis , *PNEUMONIA , *PNEUMONIA diagnosis , *ANTI-infective agents , *BODY fluids , *DIFFERENTIAL diagnosis , *PNEUMOCYSTIS pneumonia , *SULFAMETHOXAZOLE , *TRIMETHOPRIM , *DISEASE complications - Abstract
We recently treated a patient with intractable ulcerative colitis complicated with Pneumocystis carinii pneumonia in whom sulfamethoxazole/trimethoprim caused pneumonitis. The pneumonitis was difficult to differentiate from worsening of the infection or the appearance of another opportunistic infection. The patient's history of sulfasalazine (sulfonamide)-induced pneumonitis made diagnosis possible. The CD4/CD8 ratio of lymphocyte subsets in bronchoalveolar lavage fluid was decreased at the diagnosis of Pneumocystis carinii pneumonia and this ratio had increased when drug-induced pneumonitis was diagnosed. Topical administration of beclomethasone dipropionate by enema was a safe and effective for the treatment of such a compromised patient with active colitis. [ABSTRACT FROM AUTHOR]
- Published
- 1998
- Full Text
- View/download PDF
8. Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury.
- Author
-
Hasuzawa, Nao, Tatsushima, Keita, Wang, Lixiang, Kabashima, Masaharu, Tokubuchi, Rie, Nagayama, Ayako, Ashida, Kenji, Ogawa, Yoshihiro, Moriyama, Yoshinori, and Nomura, Masatoshi
- Subjects
- *
NUCLEOTIDES , *ADENOSINE triphosphate , *PURINERGIC receptors , *FATTY liver , *FIBROSIS , *HEPATITIS - Abstract
The vesicular nucleotide transporter (VNUT) is responsible for the vesicular storage and release of ATP from various ATP-secreting cells, and it plays an essential role in purinergic signaling. Although extracellular ATP and its degradation products are known to mediate various inflammatory responses via purinoceptors, whether vesicular ATP release affects steatohepatitis and acute liver injury is far less understood. In the present study, we investigated the effects of clodronate, a potent and selective VNUT inhibitor, on acute and chronic liver inflammation in mice. In a model of methionine/choline-deficient diet-induced non-alcoholic steatohepatitis (NASH), the administration of clodronate reduced hepatic inflammation, fibrosis, and triglyceride accumulation. Clodronate also protected mice against high-fat/high-cholesterol diet-induced steatohepatitis. Moreover, prophylactic administration of clodronate prevented d-galactosamine and lipopolysaccharide-induced acute liver injury by reducing inflammatory cytokines and hepatocellular apoptosis. In vitro, clodronate inhibited glucose-induced vesicular ATP release mediated by VNUT and reduced the intracellular level and secretion of triglycerides in isolated hepatocytes. These results suggest that VNUT-dependent vesicular ATP release plays a crucial role in the recruitment of immune cells, cytokine production, and the aggravation of steatosis in the liver. Pharmacological inhibition of VNUT may provide therapeutic benefits in liver inflammatory disorders, including NASH and acute toxin-induced injury. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Mortality and neurological outcomes in extremely and very preterm infants born to mothers with hypertensive disorders of pregnancy.
- Author
-
Nakamura, Noriyuki, Ushida, Takafumi, Nakatochi, Masahiro, Kobayashi, Yumiko, Moriyama, Yoshinori, Imai, Kenji, Nakano-Kobayashi, Tomoko, Hayakawa, Masahiro, Kajiyama, Hiroaki, Kikkawa, Fumitaka, and Kotani, Tomomi
- Subjects
- *
HYPERTENSION in pregnancy , *HEMORRHAGE , *PERIVENTRICULAR leukomalacia ,PREMATURE infant death - Abstract
To evaluate the impact of maternal hypertensive disorders of pregnancy (HDP) on mortality and neurological outcomes in extremely and very preterm infants using a nationwide neonatal database in Japan. This population-based retrospective study was based on an analysis of data collected by the Neonatal Research Network of Japan from 2003 to 2015 of neonates weighing 1,500 g or less at birth, between 22 and 31 weeks' gestation. A total of 21,659 infants were randomly divided into two groups, HDP (n = 4,584) and non-HDP (n = 4,584), at a ratio of 1:1 after stratification by four factors including maternal age, parity, weeks of gestation, and year of delivery. Short-term (neonatal period) and medium-term (3 years of age) mortality and neurological outcomes were compared between the two groups by logistic regression analyses. In univariate analysis, HDP was associated with an increased risk for in-hospital death (crude odds ratio [OR], 1.31; 95% confidence interval, 1.04–1.63) and a decreased risk for severe intraventricular haemorrhage (0.68; 0.53–0.87) and periventricular leukomalacia (0.60; 0.48–0.77). In multivariate analysis, HDP was significantly associated with a lower risk for in-hospital death (adjusted OR, 0.61; 0.47–0.80), severe intraventricular haemorrhage (0.47; 0.35–0.63), periventricular leukomalacia (0.59; 0.45–0.78), neonatal seizures (0.40; 0.28–0.57) and cerebral palsy (0.70; 0.52–0.95) at 3 years after adjustment for covariates including birth weight. These results were consistent with those of additional analyses, which excluded cases with histological chorioamnionitis and which divided the infants into two subgroups (22–27 gestational weeks and 28–31 gestational weeks). Maternal HDP was associated with an increased risk for in-hospital death without adjusting for covariates, but it was also associated with a lower risk for mortality and adverse neurological outcomes in extremely and very preterm infants if all covariates except HDP were identical. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Antenatal corticosteroids and preterm offspring outcomes in hypertensive disorders of pregnancy: A Japanese cohort study.
- Author
-
Ushida, Takafumi, Kotani, Tomomi, Hayakawa, Masahiro, Hirakawa, Akihiro, Sadachi, Ryo, Nakamura, Noriyuki, Moriyama, Yoshinori, Imai, Kenji, Nakano-Kobayashi, Tomoko, and Kikkawa, Fumitaka
- Subjects
- *
HYPERTENSION in pregnancy , *CORTICOSTEROIDS , *PREMATURE infant diseases , *PERIVENTRICULAR leukomalacia , *COHORT analysis - Abstract
To estimate whether antenatal corticosteroids (ACS) improve short- and long-term preterm offspring outcomes in singleton pregnancies complicated by hypertensive disorders of pregnancy (HDP) similar to pregnancies without HDP. This population-based retrospective study was conducted based on an analysis of data collected by the Neonatal Research Network of Japan on 21,014 singleton neonates weighing ≤1,500 g between 24 and 31 weeks' gestation during 2003–2016. Logistic regression analyses were performed to compare short- and long-term offspring outcomes between mothers receiving ACS treatment and those who did not among pregnancies with HDP and without HDP. Of 21,014 neonates, 4,806 (22.9%) were born to mothers with HDP. ACS treatment was associated with significant decreases in short-term adverse outcomes in the both HDP and non-HDP groups, with similar reduced odds of neonatal death, respiratory distress syndrome, and intraventricular haemorrhage (IVH). However, ACS treatment did not significantly decrease severe IVH (aOR 0.76; 95% CI 0.51–1.13) and periventricular leukomalacia (1.14; 0.78–1.66) in the HDP group. In addition, ACS treatment in mothers without HDP significantly decreased cerebral palsy (aOR 0.70; 95% CI 0.58–084), developmental quotient scores <85 (0.79; 0.69–0.90), and composite adverse outcomes (0.85; 0.75–0.96) at 3 years of age, whereas ACS treatment in mothers with HDP did not significantly improve these outcomes (1.04; 0.69–1.57, 1.11; 0.88–1.39, 0.96; 0.75–1.22, respectively). ACS treatment was associated with significantly decreased major short-term morbidities and mortality among extremely and very preterm neonates of mothers with HDP, with ACS treatment having a decreased effect compared to that observed in neonates of mothers without HDP. Although ACS treatment has no additional effects on offspring outcomes at 3 years of age, our results did not suggest that ACS treatment should be withheld from mothers with HDP. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. The mitochondrial inner membrane protein LETM1 modulates cristae organization through its LETM domain.
- Author
-
Nakamura, Seiko, Matsui, Aiko, Akabane, Shiori, Tamura, Yasushi, Hatano, Azumi, Miyano, Yuriko, Omote, Hiroshi, Kajikawa, Mizuho, Maenaka, Katsumi, Moriyama, Yoshinori, Endo, Toshiya, and Oka, Toshihiko
- Abstract
LETM1 is a mitochondrial inner membrane protein that is required for maintaining the mitochondrial morphology and cristae structures, and regulates mitochondrial ion homeostasis. Here we report a role of LETM1 in the organization of cristae structures. We identified four amino acid residues of human LETM1 that are crucial for complementation of the growth deficiency caused by gene deletion of a yeast LETM1 orthologue. Substituting amino acid residues with alanine disrupts the correct assembly of a protein complex containing LETM1 and prevents changes in the mitochondrial morphology induced by exogenous LETM1 expression. Moreover, the LETM1 protein changes the shapes of the membranes of in vitro-reconstituted proteoliposomes, leading to the formation of invaginated membrane structures on artificial liposomes. LETM1 mutant proteins with alanine substitutions fail to facilitate the formation of invaginated membrane structures, suggesting that LETM1 plays a fundamental role in the organization of mitochondrial membrane morphology. Nakamura et al find that the mitochondrial protein LETM1 can directly modulate membrane structure in vitro and identify a conserved domain involved in modulating mitochondrial membrane morphology. This study enhances our understanding of how mitochondrial cristae are organised. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission.
- Author
-
Shinozaki, Youichi, Nomura, Masatoshi, Iwatsuki, Ken, Moriyama, Yoshinori, Gachet, Christian, and Koizumi, Schuichi
- Abstract
Microglia are highly sensitive to even small changes in the brain environment, such as invasion of non-hazardous toxicants or the presymptomatic state of diseases. However, the physiological or pathophysiological consequences of their responses remain unknown. Here, we report that cultured microglia sense low concentrations of the neurotoxicant methylmercury (MeHglow) and provide neuroprotection against MeHg, for which astrocytes are also required. When exposed to MeHglow, microglia exocytosed ATP via p38 MAPK- and vesicular nucleotide transporter (VNUT)-dependent mechanisms. Astrocytes responded to the microglia-derived ATP via P2Y1 receptors and released interleukin-6 (IL-6), thereby protecting neurons against MeHglow. These neuroprotective actions were also observed in organotypic hippocampal slices from wild-type mice, but not in slices prepared from VNUT knockout or P2Y1 receptor knockout mice. These findings suggest that microglia sense and respond to even non-hazardous toxicants such as MeHglow and change their phenotype into a neuroprotective one, for which astrocytic support is required. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. Impairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity.
- Author
-
Sakamoto, Shohei, Miyaji, Takaaki, Hiasa, Miki, Ichikawa, Reiko, Uematsu, Akira, Iwatsuki, Ken, Shibata, Atsushi, Uneyama, Hisayuki, Takayanagi, Ryoichi, Yamamoto, Akitsugu, Omote, Hiroshi, Nomura, Masatoshi, and Moriyama, Yoshinori
- Subjects
- *
ADENOSINE triphosphatase , *INSULIN resistance , *GLUCOSE metabolism , *DEPOLARIZATION (Cytology) , *CATECHOLAMINES , *HOMEOSTASIS , *LABORATORY mice - Abstract
Neuroendocrine cells store ATP in secretory granules and release it along with hormones that may trigger a variety of cellular responses in a process called purinergic chemical transmission. Although the vesicular nucleotide transporter (VNUT) has been shown to be involved in vesicular storage and release of ATP, its physiological relevance in vivo is far less well understood. In Vnut knockout (Vnut-1-) mice, we found that the loss of functional VNUT in adrenal chromaffin granules and insulin granules in the islets of Langerhans led to several significant effects. Vesicular ATP accumulation and depolarization-dependent ATP release were absent in the chromaffin granules of Vnut-1- mice. Glucose-responsive ATP release was also absent in pancreatic β-cells in Vnut-1- mice, while glucose-responsive insulin secretion was enhanced to a greater extent than that in wild-type tissue. Vnut-1- mice exhibited improved glucose tolerance and low blood glucose upon fasting due to increased insulin sensitivity. These results demonstrated an essential role of VNUTin vesicular storage and release of ATP in neuroendocrine cells in vivo and suggest that vesicular ATP and/or its degradation products act as feedback regulators in catecholamine and insulin secretion, thereby regulating blood glucose homeostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Investigation of Endogenous Compounds for Assessing the Drug Interactions in the Urinary Excretion Involving Multidrug and Toxin Extrusion Proteins.
- Author
-
Kato, Koji, Mori, Haruyuki, Kito, Tomoko, Yokochi, Miyu, Ito, Sumito, Inoue, Katsuhisa, Yonezawa, Atsushi, Katsura, Toshiya, Kumagai, Yuji, Yuasa, Hiroaki, Moriyama, Yoshinori, Inui, Ken-ichi, Kusuhara, Hiroyuki, and Sugiyama, Yuichi
- Subjects
- *
DRUG interactions , *MULTIDRUG resistance , *EXCRETION , *URINARY organ examination , *ORGANIC cation transporters , *BIOMARKERS - Abstract
Purpose: Multidrug and toxin extrusion proteins (MATEs) are multispecific organic cation transporters mediating the efflux of various cationic drugs into the urine. The present study aimed at identifying endogenous compounds in human plasma and urine specimens as biomarkers to evaluate drug interactions involving MATEs in the kidney without administration of their exogenous probe drugs. Methods: An untargeted metabolomic analysis was performed using urine and plasma samples from healthy volunteers and mice treated with or without the potent MATE inhibitor, pyrimethamine. Plasma and urinary concentrations of candidate markers were measured using liquid chromatography-mass spectrometry. Transport activities were determined in MATE- or OCT2-expressing HEK293 cells. The deuterium-labeled compounds of candidates were administered to mice for pharmacokinetics study. Results: Urinary excretion of eleven compounds including thiamine and carnitine was significantly lower in the pyrimethamine-treatment group in humans and mice, whereas no endogenous compound was noticeably accumulated in the plasma. The renal clearance of thiamine and carnitine was decreased by 70%-84% and 90%-94% ( p < 0.05), respectively, in human. The specific uptake of thiamine was observed in MATE1-, MATE2-K- or OCT2-expressing HEK293 cells with K of 3.5 ± 1.0, 3.9 ± 0.8 and 59.9 ± 6.7 μM, respectively. The renal clearance of carnitine- d was decreased by 62% in mice treated with pyrimethamine. Conclusions: Our findings indicate that MATEs account for the efflux of thiamine and perhaps carnitine as well as drugs into the urine. The urinary excretion of thiamine is useful to detect drug interaction involving MATEs in the kidney. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.